A new sickle cell treatment produced in Senegal is offering hope to patients by reducing costs and addressing shortages of imported medicines. The treatment is described as affordable and locally made. It aims to improve access to care for those with sickle cell disease. The development could ease the burden on patients who rely on expensive imports.
Don't miss out on breaking stories and in-depth articles.
